PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
December 10, 2025Nature Communications8 citationsOpen Access

Efficient high-precision transgene knock-in by Recombinases (Redα/β)-enhanced DNA integration-CRISPR-Cas9 (RED-CRISPR)

View Full Paper
WLWenqing LiSLSenquan LiuXFXiaoyu Fang

Key Points

  • This research aims to present a new method for enhancing DNA integration using CRISPR-Cas9.
  • Developed RED-CRISPR using Recombinases to enhance homology-directed repair (HDR) efficiency.
  • Evaluated knock-in efficiency across various cell types including CAR-T cells and genetically modified mice.
  • Compared RED-CRISPR head-to-head with existing methods to quantify improvements in knock-in rates and off-target effects.
  • Achieved up to 45% knock-in efficiency in CAR-T cell manufacturing.
  • Attained 43% knock-in rate using 8-kb DNA cargo in genetically modified mice.
  • Enhanced HDR efficiencies by 2- to 5-fold and further improved rates by 1.5- to 2.5-fold with combined strategies.

Abstract

CRISPR-Cas9 tools have revolutionized genetic engineering, yet the efficient precise integration of DNA cargos, particularly for large DNA payloads (>1 kilobase, kb), remains a technical bottleneck. Herein, we develop a Recombinases (Redα/β)-enhanced DNA integration-CRISPR-Cas9 approach, referred to as RED-CRISPR, which offers a versatile yet robust homology-directed repair (HDR) strategy enabling efficient and precise kb-scale DNA insertion across various cell types, including immortalized and primary cells of variable origins. RED-CRISPR significantly enhances HDR efficiencies by 2- to 5-fold change across diverse loci and further elevates HDR rates by 1.5- to 2.5-fold when synergizing with other HDR-enhancing strategies. We achieved up to 45% knock-in efficiency for CAR-T cell manufacturing, and attained 43% knock-in rate for generation of genetically modified mice using an 8-kb DNA cargo. Through a head-to-head comparison, RED-CRISPR profoundly mitigates off-target mutational burden and chromosomal translocations. We envision RED-CRISPR as a powerful genome-editing tool with broad biomedical and therapeutic applications.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Li et al. (2025) studied this question.

synapsesocial.com/papers/69401b262d562116f28f79bfhttps://doi.org/10.1038/s41467-025-67239-w
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1DNA Ligase IV Mutations Identified in Patients Exhibiting Developmental Delay and Immunodeficiency2001 · 542 citations
  2. 2Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures2011 · 494 citations
  3. 3Origins and evolution of the recA / RAD51 gene family: Evidence for ancient gene duplication and endosymbiotic gene transfer2006 · 295 citations
  4. 4dCas9-based gene editing for cleavage-free genomic knock-in of long sequences2022 · 81 citations
  5. 5Enhancement of homology-directed repair with chromatin donor templates in cells2020 · 29 citations